By physician referral or invitation only

A study to see if memantine protects the brain during radiation therapy treatment for a brain tumor

The purpose of this study is to to determine the efficacy (as measured by Neurocognitive testing) of oral memantine administered for a period of 6 months, when compared to placebo, in children ages 4-18 receiving cranial or craniospinal radiotherapy for primary central nervous system tumors.

Age & Gender

4 years ~ 17.99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

David Kram
Pediatrics - Hematology/Oncology

Study Type

Clinical or Medical
Interventional

Study Topics

Brain, Head, Nervous System
Cancer (Brain and Other Nervous System, Pediatric Cancers)
Child and Teen Health

IRB Number

23-0794

ClinicalTrials.gov

NCT04939597

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.